drugset / Trial / NCT00870441
Study Comparing the Safety of ASP2151 to Valacyclovir and Placebo in Healthy Volunteers
RandomizedParallel-groupQuadruple-blind
Summary
The objective of the study is to compare the safety of ASP2151 to valacyclovir and placebo in healthy male and female adult volunteers.
Timeline
- Start
- 2009-03
- Primary completion
- 2010-04
- Completion
- 2010-04
Outcome
Outcome not reported
Stopped: “Study terminated due to treatment-emergent serious adverse events”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amenamevir | Small molecule | — | Oral |
| Comparator | Valacyclovir | Unknown | — | Oral |
Indications
No indication recorded.